INTRODUCTION {#S1}
============

Ras plays a central role in cell growth, differentiation, and apoptosis and is a member of a large superfamily of guanine nucleotide binding proteins whose activity is regulated by cycling between inactive GDP--bound and active GTP--bound states^[@R1]^. Conformational changes associated with the GDP-- and GTP--bound states are localized primarily to two regions, Switch I (residues 30--37) and Switch II (60--76), and these conformational changes direct specific interactions with regulators and effectors^[@R2],[@R3]^. Ras effectors recognize the GTP--bound state of Ras with higher affinity than the GDP--bound state, and these effectors serve to initiate downstream signaling events. Ras has weak intrinsic GTPase activity, but it does not act alone^[@R4]^. The guanine nucleotide state of Ras is regulated by two distinct types of protein modulators, which act in opposition to one another. Guanine nucleotide exchange factors (GEFs) facilitate exchange of GDP with GTP to promote Ras activation^[@R5]^ whereas GTPase--activating proteins (GAPs) stimulate the hydrolysis of GTP and Ras deactivation^[@R6]^. Ras is the most prevalent oncogene found in human cancer; about 30% of human tumors contain an activating Ras mutation^[@R7],[@R8]^. Most commonly, transforming Ras mutations decrease the sensitivity of the protein to GAP--mediated regulation^[@R9]^.

While the roles of GEFs and GAPs have been extensively characterized, it is less clear how some post--translational modifications, like monoubiquitination, contribute to Ras function and signaling. Monoubiquitination is a dynamic and reversible modification that can orchestrate cellular events including DNA repair, gene expression, endocytosis, and nuclear export^[@R10]^. Emerging evidence suggests that monoubiquitination regulates large and small GTPases, including Ras^[@R11]--[@R14]^. Monoubiquitination of K--Ras at position 147 has been shown to promote tumorigenesis^[@R15]^; mutation of oncogenic K--Ras to prevent monoubiquitination (Ras^K147L^) impaired its ability to promote tumor growth when ectopically expressed in NIH 3T3 mouse fibroblasts. These findings suggest that Ras activity and signaling are modulated by monoubiquitination, in the manner of an oncogenic mutation or receptor stimulus. Left unresolved is the mechanism by which monoubiquitination leads to activation of Ras.

Here, we set out to identify the molecular mechanism through which Ras activity is regulated by monoubiquitination. We show that monoubiquitination at position 147 does not alter the intrinsic biochemical properties of Ras, but severely disrupts regulation of Ras by GAPs. This effect is specific to monoubiquitination at position 147 and is not observed when Ras is monoubiquitinated at other adjacent lysines. The loss of GAP--mediated hydrolysis accounts for the accumulation of Ras--GTP *in vivo.* Thus, as with oncogenic mutations of Ras, monoubiquitination renders the protein resistant to GAP--mediated regulation.

RESULTS {#S2}
=======

Monoubiquitination of Ras {#S3}
-------------------------

We conducted a series of *in vitro* studies to elucidate the mechanism of Ras regulation by monoubiquitination. These studies required fully ubiquitinated protein that was exclusively modified at Lys147 and in quantities sufficient for detailed biochemical and biophysical analysis. Recent investigations of monoubiquitinated substrates and ubiquitinating enzymes employed multiple methods of direct chemical ligation to generate the protein--Ubiquitin linkage^[@R16]--[@R21]^. In our approach, we replaced the native Ubiquitin linkage with a disulfide bond between a substituted cysteine at position 147 of Ras (Ras^K147C^) and a cysteine at the carboxyl--terminus (c--terminus) of Ubiquitin (Ubiquitin^G76C^). A surface accessible cysteine (Cys118) in Ras was replaced with serine to avoid unwanted modification (Ras^C118S^, hereafter "Ras"). We previously showed that the C118S mutation did not alter Ras structure or biochemical properties^[@R22]^. The chemical ligation method does not require complicated intermediate chemical or enzymatic steps but instead provides a simple, specific approach to ubiquitination. The disulfide ligation strategy, using a more complicated cysteamine intermediate, was validated in previous studies of Proliferating Cell Nuclear Antigen (PCNA), where it was shown that chemically and enzymatically monoubiquitinated PCNA exhibit identical catalytic properties^[@R17]^. As seen in [Figure 1a](#F1){ref-type="fig"}, we drove Ubiquitin modification of Ras at position 147 to completion by the addition of a ten--fold excess of Ubiquitin^G76C^ at pH 8.0. We conducted our experiments using H--Ras (1--166), for which the biochemical and structural (NMR and X--Ray) properties are best established, but corroborated the results using K--Ras (1--166) as indicated. All three mammalian isoforms H--, K--, and N--Ras show similar biochemical properties in the absence of the hypervariable c--terminus^[@R23],[@R24]^. Furthermore, we used immunoprecipitation assays to show that, in the absence of c--terminal modification, monoubiquitination still leads to an increase in the GTP--bound population of H--Ras or K--Ras in HEK293T cells ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}).

Downstream effectors of Ras, like Raf, have a Ubiquitin--like fold^[@R25]^. Thus, we considered whether Ubiquitin could bind to Ras in the manner of an effector. To this end, we used NMR in the presence of free unlabeled Ubiquitin to determine whether Ubiquitin altered spectral features associated with Ras backbone amides. A ^1^H--^15^N 2D HSQC overlay of ^15^N--enriched H--Ras^K147C^ in the absence and presence of Ubiquitin is shown in [Figure 1b](#F1){ref-type="fig"}. The assignments for H Ras (1--166) were previously determined^[@R26]^ and we verified the shifted backbone amide resonances of H--Ras^K147^ using 3D HNCACB data ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). Comparison of the position and intensity of the backbone amide resonances indicates that Ras is not altered by the presence of free Ubiquitin. In support of these observations, as shown in [Figure 2a--b](#F2){ref-type="fig"} and [Supplementary Figure 3](#SD1){ref-type="supplementary-material"}, we found that the intrinsic rate of GDP dissociation and GTP hydrolysis were unaffected by the presence of Ubiquitin or Ubiquitin dimers in solution. These results indicated that Ras did not specifically interact with Ubiquitin. Therefore, for subsequent analyses, we did not separate monoubiquitinated Ras (mUbRas) from free Ubiquitin.

Monoubiquitinated Ras Retains Intrinsic GTPase Activity {#S4}
-------------------------------------------------------

Previous computational studies predicted that the stability of a ubiquitinated substrate depends on the site of ubiquitination and type of Ubiquitin--Ubiquitin linkage^[@R27]^. To determine if monoubiquitination alters Ras, we compared the thermal stability of unmodified Ras and mUbRas. To this end, we employed the Quantitative Cysteine Reactivity (fQCR) assay^[@R28]^, which uses a cysteine reactive dye to measure rates of protein unfolding as a function of temperature. Because Ubiquitin does not have any native cysteines, it is invisible by this method. As shown in [Figure 2c](#F2){ref-type="fig"}, we found that monoubiquitination decreases the thermal stability of Ras by 3.5 degrees (43.1± 0.2 °C, 39.2 ± 0.3 °C, and 39.6 ± 0.2 °C for Ras, Ras^K147A^, and mUbRas, respectively), a change that is not likely to have a substantial effect on this otherwise highly stable protein *in vivo*. These data suggest that, despite the size of Ubiquitin, monoubiquitination at position 147 does not lead to thermal destabilization of Ras.

While monoubiquitination of Ras does not substantially affect thermal stability, it could alter intrinsic activity. For example, it is possible that ubiquitination impairs guanine nucleotide binding, similar to mutations at the adjacent residue, Ala146 (refs. [@R29],[@R30]). To measure rates of nucleotide dissociation, we equilibrated Ras and mUbRas with the fluorescent analog N--methylanthraniloyl (MANT)--GDP and measured fluorescence over time in the presence of excess unlabeled GDP. We observed a slight increase (2--3 fold) in the intrinsic rate of nucleotide dissociation for Ras^K147C^ as compared to native Ras, while the rate for mUbRas was unaltered ([Fig. 2a](#F2){ref-type="fig"}). This result suggests that ubiquitination of Ras does not have the same impact on nucleotide binding as a point mutation at the same residue.

We next sought to establish whether monoubiquitination alters the intrinsic rate of GTP hydrolysis. To this end we measured single turnover GTP hydrolysis using Flippi, a fluorescent sensor that detects free phosphate^[@R31]^. As shown in [Figure 2b](#F2){ref-type="fig"} and [Supplementary Figure 4](#SD1){ref-type="supplementary-material"}, neither mutation of Lys147 nor monoubiquitination of Ras affected the intrinsic rate of GTP hydrolysis (calculated as 0.012 ± 0.002 min^−1^ for all variants). Taken together, these results indicate that monoubiquitination does not alter the activity of Ras, and that another mechanism must account for the accumulation of mUbRas in the GTP--bound state *in vivo*.

Chemical Ubiquitination Mimics Native Ubiquitination {#S5}
----------------------------------------------------

We found that monoubiquitination does not alter the intrinsic biochemical activity of Ras, even though mUbRas accumulates in the GTP--bound state *in vivo*. Previous studies have shown that chemically ubiquitinated PCNA functions similarly to the enzymatically ubiquitinated protein^[@R17]^. To further establish that chemical ubiquitination of Ras is a good mimic of native ubiquitination, we built computational models of Ubiquitin ligated to Ras.

To create the model, we used a recently developed module of the Rosetta protein modeling software suite^[@R32],[@R33]^ that samples the conformational space available to ligated proteins. We modified Rosetta to consider disulfide and native isopeptide ubiquitination linkages and generated model structures of mUbRas using both linkages. We generated these models without the use of experimentally--derived constraints.

Shown in [Figure 3a and 3b](#F3){ref-type="fig"} are the ten lowest scoring structures of each type of linkage, sorted by Rosetta total score from populations of approximately 2000 models. Comparison of these models indicates that the two systems behave similarly; Ubiquitin samples a wide range of conformations when ligated to Ras and all Ubiquitin positions are allowed at low energy scores. ([Figure 3c and 3d](#F3){ref-type="fig"}). This modeling result suggests that chemical ubiquitination is a good surrogate for native ubiquitination of Ras. The data also suggest that Ubiquitin does not bind with high affinity to any single site on Ras, which is consistent with our findings that Ubiquitin does not specifically interact with Ras when the two proteins are free in solution.

Monoubiquitination Affects the Switch Regions of Ras {#S6}
----------------------------------------------------

Results obtained from computational modeling suggest that there is no single preferred interaction between Ubiquitin and Ras. To test this prediction experimentally, we used NMR to examine spectral differences between Ubiquitin and Ras upon monoubiquitination. First, we ^15^N--enriched Ubiquitin^G76C^ and examined the ^1^H--^15^N 2D HSQC spectrum of Ubiquitin when ligated to Ras^K147C^. By this method we observed partial to complete resonance broadening of eleven backbone amides, but no substantial chemical shifts within Ubiquitin ([Fig. 4a](#F4){ref-type="fig"}). By mapping these spectral changes onto the structure of Ubiquitin in [Figure 4b](#F4){ref-type="fig"}, it is evident that one face of Ubiquitin is primarily altered upon ligation with Ras. A possible explanation for the inability to detect a subset of Ubiquitin amide resonances is that Ras ligation restricts conformational sampling, leading to exchange broadening.

We next reversed our labeling scheme and ^15^N--enriched Ras prior to ligation with Ubiquitin and collected a ^1^H--^15^N 2D HSQC spectrum. As shown in [Figure 4c](#F4){ref-type="fig"}, a number of NH peaks broaden in mUbRas relative to the unmodified protein. Eighty--four of the 137 detectable backbone amide resonances dispersed across mUbRas exhibited multiple populations rather than a single, Lorentzian shaped peak ([Supplementary Figure 5](#SD1){ref-type="supplementary-material"}). The multiple populations indicate that Ubiquitin adopts more than one position relative to Ras on a timescale detectable by NMR. We also observed a substantial number of residues that broadened and, in some cases, could no longer be detected in mUbRas ([Fig. 4c](#F4){ref-type="fig"}). The broadened peaks primarily localize to the switch regions ([Fig. 4d](#F4){ref-type="fig"}). In the NMR spectra of Ras--GTP, backbone amides associated with residues in Switch I and Switch II are not detectable because they are in intermediate exchange on the NMR timescale^[@R34]^. The observed broadening in the GDP--bound state of mUbRas suggests a change in backbone dynamics, possibly due to conformational exchange or dynamic sampling of the switch regions. Since Ras regulators and effectors interact through the switch regions, monoubiquitination could alter the population of active Ras by changing how mUbRas interacts with regulators.

Monoubiquitination of Ras Inhibits GAP--Mediated Hydrolysis {#S7}
-----------------------------------------------------------

In cells, the nucleotide--bound state of Ras is regulated both by GEFs, which increase the rate of GDP dissociation, and GAPs, which enhance the rate of GTP hydrolysis. Our NMR data suggest that monoubiquitination affects the switch regions of Ras, which in turn could alter interactions with GEFs and GAPs. Thus the increased GTP--bound population of mUbRas *in vivo* could be caused by either an increased sensitivity to GEFs or decreased sensitivity to GAPs.

We first determined if the rate of GEF--mediated GDP dissociation is altered when Ras is monoubiquitinated. For these experiments, we equilibrated Ras^K147C^, mUbRas, and Ras with MANT--GDP, and measured the rate of GDP dissociation in the presence of a catalytic fragment from the Ras GEF, Sos (Sos^cat^)^[@R35]^. While the rate of GEF--mediated GDP dissociation was faster for Ras^K147C^ than Ras, the percent increase compared to the intrinsic rate of dissociation was the same, indicating that mutation at position 147 does not change the overall sensitivity of Ras to GEF--mediated regulation. However, we observed a decrease in the rate of GEF--mediated nucleotide dissociation for mUbRas compared to unmodified Ras ([Fig. 5a](#F5){ref-type="fig"}).

We next considered the effect of Ras monoubiquitination on GAP--mediated hydrolysis. To this end we compared the rate of GTP hydrolysis for Ras and mUbRas in the presence of the catalytic domains of two GAPs, NF1 (NF1^333^) and p120GAP(GAP--334)^[@R4],[@R36]^. At a GAP--to--Ras ratio of 1:500, we observed an order of magnitude increase in the rate of GTP hydrolysis for unmodified Ras relative to the intrinsic rate of GTP hydrolysis. No increase in the rate of GTP hydrolysis was observed for mUbRas in the presence of the same GAP--to Ras ratio ([Fig. 5b](#F5){ref-type="fig"}). Therefore, mUbRas is insensitive to GAP--mediated regulation, similar to an oncogenic Ras^G12V^ mutation^[@R9]^. We obtained similar results using K--Ras ([Supplementary Figure 6](#SD1){ref-type="supplementary-material"}), indicating that the effects of monoubiquitination on Ras are not isoform--specific.

To verify that the differences between the enzymatic and chemical ubiquitination linkers (seven bonds and five bonds, respectively) do not alter GAP--responsiveness, we placed an additional cysteine at the c--terminus of Ubiquitin (Ubiquitin^C77^), thereby creating a linker one bond longer than the native linker. We measured the rate of GAP--mediated GTP hydrolysis and observed that the response of Ras ligated to Ubiquitin^C77^ was identical to Ras ligated to Ubiquitin^G76C^ ([Fig. 5b](#F5){ref-type="fig"}). These results indicate that variations in the linker length on this scale (1--2 bonds) do not influence the sensitivity of mUbRas to GAP downregulation.

To validate the use of an *in vitro* system to dissect the mechanism of Ras regulation, we measured the sensitivity of mUbRas to GAP--mediated hydrolysis in a cellular reconstitution system. We immunoprecipitated Ras from HEK293T cells and compared the sensitivity of the monoubiquitinated and unmodified fractions of Ras to regulation by GAP. As seen in [Figure 5c](#F5){ref-type="fig"}, monoubiquitinated K--Ras is less sensitive than the unmodified protein to GAP--mediated GTP hydrolysis. These data support our *in vitro* findings that monoubiquitination increases the population of active, GTP--bound Ras through a defect in sensitivity to GAP--mediated regulation.

To determine if the reduced response to regulators is due to a change in binding affinity for mUbRas, we first measured the extent to which monoubiquitination disrupts the interaction between Ras and Sos^cat^ ([Fig. 5d](#F5){ref-type="fig"}). Results from these analyses indicated that the binding affinity between mUbRas and Sos^cat^ is 8.3 ± 0.9 μM, which is half the observed binding affinity between Ras and Sos^cat^ (4.2 ± 0.4 μM), consistent with the small reduction in the rate of GDP dissociation observed. However, a decrease in the rate of GDP dissociation would favor the GDP--bound state of Ras. Thus, the minor differences in GEF binding do not account for the accumulation of Ras--GTP *in vivo.*

To determine whether ubiquitination also leads to a reduction in GAP binding affinity, we compared the ability of Ras and mUbRas to bind to NF1^333^ in the presence of AlF~4~^−^. As seen in [Figure 5e](#F5){ref-type="fig"}, in the presence of AlF~4~^−^ almost 100% of NF1^333^ bound to Ras, which was present in slight excess. In contrast, about 50% of the NF1^333^ bound to mUbRas under the same conditions ([Fig. 5f](#F5){ref-type="fig"}), which suggests that the binding affinity between GAP and mUbRas is reduced relative to unmodified Ras. While monoubiquitination affects both GEF--and GAP--mediated activity, the GAP defect has a greater influence on the enzyme kinetics and as such is predicted to have a dominant effect on the contribution to GTP--bound Ras. These data are supported by kinetic modeling of the respective GEF and GAP defects shown in [Supplementary Figure 7](#SD1){ref-type="supplementary-material"}. Taken together, our data reveal a substantial reduction in GAP activity as a consequence of Ras monoubiquitination, which accounts for the accumulation of activated Ras *in vivo*.

Modifying Ras with PDZ2 Impairs GAP--Mediated Hydrolysis {#S8}
--------------------------------------------------------

Our computational and NMR data suggest that Ubiquitin does not form a specific, high--affinity interaction with Ras. If this observation is correct, then modification of Ras with any protein similar to Ubiquitin should also impair GAP--mediated hydrolysis. As a test of this model, we chemically ligated Ras to PDZ2 (RasPDZ2), a 9 kDa protein with a Ubiquitin--like fold but no obvious sequence similarity to Ubiquitin^[@R37]^. We replaced the unstructured c--terminal extension of PDZ2, defined as the region after the folded domain ends in the crystal structure, with that of Ubiquitin (PDZ2^UL^). Therefore, all differences between PDZ2^UL^ and Ubiquitin are contained in the folded regions of the two proteins.

Modeling of PDZ^UL^ on Ras shows that PDZ adopts a similar spread of possible conformations as Ubiquitin ([Fig. 6a and 6b](#F6){ref-type="fig"}), suggesting that it could have an impact on Ras activity that is comparable to that of Ubiquitin ligation. As seen in [Figure 6c](#F6){ref-type="fig"}, mUbRas and RasPDZ2^UL^ have identical melting temperatures, indicating that neither ubiquitination nor PDZ2^UL^ ligation substantially alters the thermal stability of Ras. Similar to ubiquitination, PDZ2^UL^ ligation does not alter intrinsic Ras nucleotide dissociation rates, and GEF--mediated dissociation is reduced to the same extent as for mUbRas ([Fig. 6d](#F6){ref-type="fig"}). Finally, RasPDZ2^UL^ retains intrinsic GTP hydrolysis activity, but is insensitive to GAP--mediated GTP hydrolysis ([Fig. 6e](#F6){ref-type="fig"}). These data indicate that non--specific interactions between Ras and Ubiquitin are responsible for the insensitivity of mUbRas to GAPs.

The Effect of Ubiquitination is Site--Specific {#S9}
----------------------------------------------

Finally, while the GAP insensitivity of modified Ras is not specific to Ubiquitin, it could be specific to modification at position 147. To address this possibility, we chose two other lysines on Ras that were not identified as sites of monoubiquitination in the mass spectrometry screen of monoubiquitinated K--Ras^[@R15]^. We chose position 88 because it is near the switch regions of Ras, similar to position 147, and could have a similar effect as monoubiquitination at position 147. We chose position 101 because the side chain is oriented toward the opposite face of Ras and would likely be less disruptive to the Ras active site and switch regions if monoubiquitinated ([Figure 7a](#F7){ref-type="fig"}).

Using our Rosetta models, we found that monoubiquitination of Ras at position 88 or 101 does not cause steric clashes with GAP--334, similar to monoubiquitination at position 147 ([Supplementary Figure 8](#SD1){ref-type="supplementary-material"}). To determine whether monoubiquitination at position 88 or 101 could affect GAP--mediated regulation, we mutated each of these residues to cysteine, modified them with Ubiquitin^G76C^, and measured the effect of Ubiquitination on intrinsic and GAP--mediated GTP hydrolysis. As seen in [Figure 7b](#F7){ref-type="fig"}, ubiquitination at position 88 or 101 of Ras does not affect the intrinsic or GAP--mediated rate of GTP hydrolysis. Only monoubiquitination at position 147 impairs GAP--mediated hydrolysis, indicating that the outcome of monoubiquitination is site--specific.

In summary, we used a combination of biochemical, structural, and computational approaches to uncover the mechanism of Ras regulation by monoubiquitination. Our data indicate that ubiquitination activates Ras by impairing the catalytic efficiency of Ras GAPs. Furthermore, the most commonly ubiquitinated position *in vivo*, position 147, is the only lysine tested that impairs GAP--mediated hydrolysis. More broadly, our findings reveal how monoubiquitination promotes sustained signaling and cell transformation.

DISCUSSION {#S10}
==========

It was established recently that monoubiquitination increases the proportion of Ras that is in the activated (GTP--bound) state, that monoubiquitination enhances association with the downstream effectors Raf and PI3--Kinase, and that mutation of the primary site of monoubiquitination impairs oncogenic Ras--mediated tumorigenesis. Here we show that monoubiquitination decreases the sensitivity of Ras to GAP--mediated hydrolysis. A major advance was our ability to easily generate mUbRas, modified at a single site, in a form suitable for detailed biophysical studies. This chemical ligation strategy will likely be useful for the study of other monoubiquitinated proteins. Surprisingly, monoubiquitination did not alter the intrinsic activity of Ras, despite the size of the modification. Our modeling and NMR analyses indicated that Ubiquitin dynamically samples a broad surface area of Ras that alters switch region dynamics. These results led us to examine the effect of monoubiquitination on the interaction of Ras with its cognate GEF and GAPs, which also target the switch domains. The analysis revealed that monoubiquitination abrogates GAP--mediated GTP hydrolysis. All other activities, including the ability to bind regulators, were largely preserved and our kinetic modeling suggests that the GAP defect will dominate. Furthermore, this outcome was specific to monoubiquitination at position 147. Thus our work establishes an entirely new mode of Ras activation in which signaling is sustained even in the absence of hormone stimulus or oncogene mutation.

It will be interesting to determine how monoubiquitination affects other signaling proteins including other Ras--family GTPases. Known targets of monoubiquitination include K--Ras^[@R15]^, H--Ras, and N--Ras^[@R11]^. Monoubiquitination disrupts interactions of Rap2A with effector proteins and inhibits the ability of Rap2A to promote dendrite development^[@R12]^. Monoubiquitination has also been observed in Rac1, although the biological consequence of this modification is not yet known^[@R13],[@R14]^. Our chemical ligation strategy and multi--dimensional approach will be useful for the study of these targets, particularly in cases where the relevant ubiquitin ligase has not been identified.

Another question concerns the role of the preferred site of monoubiquitination, Lys147 (ref. [@R15]). Whereas ubiquitination of this site has severe consequences for GAP function, targeted ubiquitination of two other candidate sites left GAP--mediated hydrolysis unperturbed. Lys147 is part of the SAX motif, and a lysine at the third position in this motif is conserved in Ras proteins across species, as well as in other Ras--family GTPases including RhoA, RhoB, RhoC, Rap, Ral, Rab, Rheb and Ran^[@R38]^. It has been shown previously that mutation of the highly conserved adjoining residue, Ala146, leads to enhanced GDP exchange, GTP loading and cellular transformation^[@R29],[@R30],[@R39]^. In contrast, we have shown that a mutation of the ubiquitination site itself, Lys 147, has little effect on nucleotide binding or regulator--mediated activity. We speculate that the lysine has been conserved to allow regulation through monoubiquitination. It will be interesting to determine whether other members of the Ras subfamily are also ubiquitinated at this position and whether ubiquitination in such cases leads to sustained activation.

Conclusions {#S11}
===========

We have demonstrated that monoubiquitination of Ras impedes the function of GTPase activating proteins. Key to our analysis was the ability to generate monoubiquitinated protein, modified at a single residue, suitable for biophysical analysis. Through multi--disciplinary computational, structural and biochemical approaches we identified a novel mechanism of Ras activation, one that is independent of any oncogenic mutation or a sustained receptor stimulus. Given the established importance of Ras in the control of cell growth and differentiation, our findings may reveal opportunities for new pharmaceuticals that target the ubiquitination machinery.

ONLINE METHODS {#S12}
==============

Protein Purification {#S13}
--------------------

The Ras domains (1--166) of H--Ras and K--Ras were expressed in the pQlinkH vector (Addgene) with a histidine purification tag in *Escherichia coli* BL21 (DE3) RIPL cells (Stratagene: La Jolla, CA). Proteins were purified following standard Qiagen nickel affinity purification procedures. The His tag was cleaved overnight with Tobacco Etch Virus. Ras proteins were further purified by removal of uncleaved protein using Ni--NTA agarose beads (Qiagen). The final product was \> 95% pure by SDS--PAGE. Proteins were stored in 20 mM HEPES, pH 8.0, 50 mM NaCl, 500 μM TCEP, 50 μM GDP and 5 mM MgCl~2.~

Sos^cat^ (John Kuriyan; University of California, Berkeley) was purified as previously described^[@R35]^. The catalytic domains of p120GAP (GAP--334) ^[@R4]^ and NF1 (NF1^333^)^[@R36]^, were expressed in pQlinkH and purified as described for Ras. Purified proteins were stored in 20 mM HEPES, pH 8.0, 50 mM NaCl and 500 μM TCEP. Full length Ubiquitin^G76C^ and hPTPe--PDZ2 ^ULG97C^ (c--terminal residues KGQSPC replaced with the Ubiquitin residues VLRLRGC)^[@R37]^ were expressed in the pQlinkH vector system and purified as described for Ras. Proteins were stored in 20 mM HEPES, pH 8.0, 50 mM NaCl and 500 μM TCEP.

Ligation of Ubiquitin^G76C^ and PDZ2 ^ULG97C^ to Ras^K147C^ {#S14}
-----------------------------------------------------------

The chemical ligation strategy used to link Ras to Ubiquitin^G76C^ or PDZ2^ULG97C^ was adapted from Merkley et al.^[@R16]^. Briefly, a ten--fold excess of Ubiquitin^G76C^ or PDZ2 ^ULG97C^ was added to Ras^K147C^ and dialyzed into 20 mM Tris, pH 8.0, 50 mM NaCl, 5 mM MgCl~2~, and 50 μM GDP at 4 °C overnight. The amount of disulfide complex formation was determined by non--reducing SDS--PAGE and considered complete by the absence of modified Ras.

Thermal Stability of Ras {#S15}
------------------------

The fast quantitative cysteine reactivity (fQCR) method^[@R28]^ was employed to measure changes in Ras thermal stability. Briefly, 2 μM Ras was incubated with 1 mM 4--fluoro--7--aminosulfonylbenzofurazan (ABD--F, Anaspec) at pH 7.0 in the presence of 20 μM GDP and 2 mM MgCl~2~ at the desired temperature for five minutes. Fluorescent intensity was measured on a PHERAstar plate reader (BMG Labtech). The data were normalized and fit to determine the temperature at which half the protein was unfolded, representing the T~m~. Results are the mean ± s.d. (n=3).

Ras Nucleotide Dissociation and Hydrolysis Assays {#S16}
-------------------------------------------------

The rate of nucleotide dissociation was measured using MANT--GDP (BioLog: San Diego, CA) as previously reported^[@R41],[@R42]^. Briefly, MANT--GDP--bound Ras (2 μM) was added to 1 mL assay buffer (50 mM Tris, pH 7.4, 50 mM NaCl and 5 mM MgCl~2~) and exchange initiated by addition of 2 mM GDP. MANT--GDP dissociation was measured as a change in fluorescence intensity over time (excitation: 360 nm, emission: 440 nm) (LS50B Perkin--Elmer Luminescence Spectrometer). Fluorescence data were fit in GraphPad Prism (GraphPad Software; San Diego, CA) to a one--phase exponential decay curve. For GEF--mediated dissociation and binding, 200 nM Ras and 0.2 μM to 20 μM Sos^cat^ were used. The nucleotide dissociation rate was plotted as a function of Sos^cat^ concentration and fit to one site binding to determine the binding affinity between Ras or mUbRas and Sos^cat^. Results are the mean ± s.d. (n=4).

Single--turnover GTP hydrolysis assays were performed as previously described^[@R43]^, except that the phosphate binding protein Flippi 5U (Addgene) was used to detect inorganic phosphate released upon GTP hydrolysis^[@R31]^. Flippi 5U was purified as previously described^[@R31]^. All buffers were made phosphate free by dialysis with 1 U nucleoside phosphorylase (Sigma, USA) and 2 mM inosine (Sigma, USA). For GAP--mediated hydrolysis, 50 μM Ras and 0.1 μM (1:500) and 0.25 μM (1:200) NF1^333^ and GAP--334 were used. The ratio of fluorescence emission was measured at 480 nm and 530 nm with an excitation of 435 nm on a SpectraMax M5 (Molecular Devices). Fluorescence ratios were converted to phosphate concentrations using a standard curve. Hydrolysis curves were fit in GraphPad Prism (GraphPad Software; San Diego, CA) to a one--phase exponential association curve. Results are the mean ± s.d. (n=6).

GAP binding was monitored as previously described^[@R44]^. Briefly, 50 μM Ras and 40 μM NF1^333^ were mixed in the presence or absence of AlF~4~^−^ (10 mM NaF, 450 μM AlCl~3~) on ice. The sample was run on an S75 column in 30 mM Tris, pH 7.5 and 5 MM MgCl~2~. Data was normalized to the amount of free NF1^333^ in the absence of AlF~4~^−^.

GST--RBD Immunoprecipitation Assay {#S17}
----------------------------------

Ras activation was measured as described previously^[@R15]^. Flag--His--K--Ras or the c--terminal mutants Flag--His--K--Ras^C185S^ and Flag--His--H--Ras^C186S^ were co--expressed with HA--Ubiquitin in HEK293T cells. The cells were rinsed with cold PBS and lysed with Buffer A (0.5% NP--40, 40 mM HEPES \[pH 7.4\], 150 mM NaCl, 10% glycerol, 1 mM DTT, 1 μg ml^−1^ leupeptin, 2 μg ml^−1^ aprotinin, 1 μg ml^−1^ pepstatin A, 100 μM AEBSF, Halt phosphatase inhibitor cocktail (Thermo Scientific), 10 mM iodoacetamide (IAA) and 5 mM *N*--ethylmaleimide (NEM)). The soluble fraction from the cell lysates were isolated by centrifugation at 13,000 rpm for 10 min, split, and subjected to anti--Flag agarose immunoprecipitation or incubated with 10 μg of GSH--Sepharose bound GST--Raf--RBD in the presence of 1 mg ml^−1^ BSA for 30 min as described previously^[@R15]^. The immunoprecipitated proteins were washed three times with Buffer A and eluted by the addition of 8 M urea. To ensure detection of mUbRas, a secondary purification on Co^2+^ Talon metal affinity chromatography beads (Clontech) was performed. Flag--His--Ras was eluted with sample buffer containing 50 mM EDTA. For the GAP sensitivity assay, bacterially produced GAP--334 was incubated with the cell lysate for 20 min at room temperature and subjected to analysis using GST--Raf--RBD.

NMR Experiments {#S18}
---------------

For NMR studies, ^15^N--and ^15^N,^13^C--enriched samples of Ras and Ubiquitin were produced using standard protocols in M--9 minimal media^26.\ 1^H--^15^N 2D HSQC experiments were conducted on a Varian 700 MHz with a cryoprobe in 20 mM MOPs, pH 6.8, 100 mM NaCl, 5 mM MgCl~2~, 0.01% sodium azide, 10% D~2~O, 1 mM DPTA, and 2 mM GDP at 25° C and with 500 μM protein.

Rosetta Modeling {#S19}
----------------

The modeling strategy used was adapted from Saha et al.^[@R32]^. The previous protocol modeled a thioester linkage between Ubiquitin Gly76 and cysteine on a Ubiquitin E2 enzyme. Modifications include altering the linkage type to disulfide or isopeptide linkages and replacing the pre--existing system--specific constraints with optional command--line defined constraints. Further modifications include the reporting of specific Ubiquitin--Ras residue pair distances and Ubiquitin--Ras positional metrics used to quantify mUbRas conformational ensembles. Also added was the ability to include arbitrary nonmoving atoms in the simulation, used to include the guanine nucleotide, magnesium ion, and in some cases, GAP during simulations. A chemically conjugated model of Ras and Ubiquitin was created and the torsion angles within the linker region were modeled while sampling side chain conformations throughout the interface.

For the isopeptide linker, protocol UBQ_Gp_LYX--cterm was used. Torsions allowed to vary included: the chi angles of Lys147 of Ras (sampled from Rosetta's implementation of Dunbrack's 2002 rotamer library^[@R45],[@R46]^), the isopeptide bond, and both phi and psi for the Gly76, Gly75, and Arg74 of Ubiquitin. For the disulfide linker, protocol UBQ_Gp_CYD--CYD was used. Torsions sampled include the chi angles for K147C on Ras and G76C on Ubiquitin (from the Dunbrack library and explicit sampling of chi 2), the disulfide bond, phi of Ubiquitin G76C, and both phi and psi for Gly75 and Arg74 of Ubiquitin.

Sampling was performed with a standard Rosetta Metropolis--Monte Carlo search protocol^[@R45]^. For each combination of ligand, attachment chemistry, and Ras attachment location, the protocol was run for 2400 hours on a 2.66 MHz chip. This produces about 1500--3000 structures using 20,000 Monte Carlo cycles per trajectory.
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![Monoubiquitination of Ras. (**a**) Reaction of Ubiquitin^G76C^ with Ras or a Ras^K147C^ mutant, under non--reducing conditions. The product of the reaction contains mUbRas, Ras, Ubiquitin--Ubiquitin dimer (Ub--Ub), and free Ubiquitin (Ub). (**b**) HSQC spectra of ^15^N--Ras^K147C^ bound to Mg--GDP in the absence (black) and presence (red) of ten--fold excess free Ubiquitin.](nihms411279f1){#F1}

![Monoubiquitinated Ras retains intrinsic stability and activity. (**a**) Intrinsic nucleotide dissociation rates for Ras, Ras^K147C^, and mUbRas loaded with MANT--GDP. Dissociation was monitored following the addition of unlabeled GDP by the decrease in fluorescence emission over time. Data were fit to an exponential dissociation curve, and the results are the mean ± s.d. (n=4). (**b**) Intrinsic single--turnover GTP hydrolysis for Ras, Ras^K147C^, and mUbRas. Hydrolysis was initiated by the addition of Mg^2+^ and monitored by the change in fluorescence of Flippi when bound to free phosphate. Data were converted to a phosphate concentration using a standard curve. The concentration of phosphate equal to 100% GTP hydrolyzed was determined in the presence of GAP. Results are the mean ± s.d. (n=6). (**c**) Thermal stability of Ras, Ras^K147A^, and mUbRas measured by 4--Fluoro--7--aminosulfonylbenzofurazan (ABD--F) incorporation as a function of temperature. The data were normalized using the maximum fluorescence intensity. Results are the mean ± s.d. (n=4).](nihms411279f2){#F2}

![Rosetta model of native and chemical ubiquitination of Ras. (**a**) The ten lowest scoring Rosetta models of the native linkage of Ras monoubiquitination at position 147 lacking constraints to bias the model. Ras (5P21) is shown in grey with switch regions (SWI and SWII) highlighted in black. Ubiquitin (1UBQ) conformers shown in colors. Inset: native linkage between Ras Lys147 and Ubiquitin G76. (**b**) The ten lowest scoring Rosetta models of the chemical linkage of Ras monoubiquitination at position 147 lacking any constraints to bias the model. Ras and Ubiquitin colored as in panel **a**. Inset: chemical linkage between Ras K147C and Ubiquitin G76C. (**c**) The distribution of Ubiquitin orientations relative to Ras plotted against Rosetta energy scores for the native linkage. The Y axis shows the dihedral angle, in degrees, of the torsional angle between the center of mass of Ubiquitin, the linking Ras residue (147), the center of mass of Ras and an arbitrary Ras reference atom. (**d**) The distribution of Ubiquitin orientations relative to Ras plotted against Rosetta energy scores for the chemical linkage. Axes are the same as described in panel **c**.](nihms411279f3){#F3}

![Surfaces of Ras and Ubiquitin affected by monoubiquitination. (**a**) HSQC spectra of ^15^N--Ubiquitin^G76C^ free (black) or ligated to Ras^K147C^ (blue). Residues that broaden are labeled based on previous assignments^[@R40]^. (**b**) Space filling model of the structure of Ubiquitin (1UBQ) with residues that show decreased intensity when ligated to Ras (blue). Residues with no information are colored black. (**c**) HSQC spectra of ^15^N--Ras^K147C^ bound to Mg--GDP alone (black) and when monoubiquitinated (green). Inset (Top): enhancement of one expanded region showing residues that broaden and disappear. Inset (Bottom Left): SDS--PAGE gel showing integrity of mUbRas sample after HSQC analysis. Inset (Bottom Right): close up of Arg135, which exhibits multiple populations. (**d**) Mapping of Ras backbone amides that disappear upon monoubiquitination onto the structure of Ras. Darker green indicates more appreciable broadening (primarily in the SW I and SW II). Residues with no information are colored black.](nihms411279f4){#F4}

![Monoubiquitination decreases the sensitivity of Ras to downregulation by GAPs. (**a**) Nucleotide dissociation reaction for Ras, Ras^K147C^, and mUbRas loaded with MANT--GDP in the presence of a 1:1 molar ratio of Ras to Sos^cat^. Data were fit to an exponential dissociation curve, and the results are the mean ± s.d. (n=4). (**b**) Single--turnover GTP hydrolysis for Ras, Ras^K147C^, mUbRas, mUbRas ubiquitinated with Ub^77C^ (mUb^77C^Ras), and Ras^G12V^ in the presence of NF1^333^ or GAP--334 at a molar ratio of 1:500 GAP:Ras. Results are the mean ± s.d. (n=6). (**c**) Immunoblotting of GTP-bound Ras and GTP-bound mUbRas in cell extract in the presence of increasing concentrations of RasGAP. Anti--Flag and anti--HA antibodies reveal the relative fraction of total Ras and mUbRas, respectively. (**d**) Titration of Ras with Sos^cat^. Experiments were performed as described panel **a**, except the concentration of Sos^cat^ was varied while Ras was held constant at 0.2 μM. Data plotted as a function of the Sos^cat^ concentration. Results are the mean ± s.d. (n=3). (**e**) Gel filtration of Ras and NF1^333^ in the absence (dotted line) and presence (solid line) of AlF~4~^−^. (**f**) Gel filtration of mUbRas and NF1^333^ in the absence (dotted line) and presence (solid line) of AlF~4~^−^.](nihms411279f5){#F5}

![Modification of Ras with PDZ2 resembles modification with Ubiquitin. (**a**) Rosetta model of Ras (5P21) in grey modified at position 147 with Ubiquitin (1UBQ) in green and PDZ^UL^ (3LNX) in purple. (**b**) The distribution of PDZ^UL^ orientations relative to Ras plotted against Rosetta energy scores for the chemical linkage. This plot follows the scheme of [Figure 3B](#F3){ref-type="fig"}. (**c**) Thermal stability of Ras and RasPDZ2 with the Ubiquitin linker (RasPDZ2^UL^) measured by ABD--F incorporation as a function of temperature. Results are the mean ± s.d. (n=4). (**d**) Nucleotide dissociation reaction for RasPDZ2^UL^ and mUbRas loaded with MANT--GDP in the absence and presence of a 1:1 molar ratio of Ras to Sos^cat^. Results are the mean ± s.d. (n=4). (**e**) Single--turnover GTP hydrolysis for Ras, RasPDZ2^UL^, and mUbRas in the presence of GAP--334 at a molar ratio of 1:500 and 1:200 GAP:Ras. Results are the mean ± s.d. (n=6).](nihms411279f6){#F6}

![The impaired GAP--sensitivity of mUbRas is site--specific. (**a**) Ribbon diagram of Ras--GDP (1CRR) with the switch regions highlighted in black and the side chains of Lys147, Lys88, and Lys101 represented as spheres in green, fuchsia, and blue, respectively. (**b**) Single--turnover GTP hydrolysis for Ras mutated and ubiquitinated at position 147, 88, or 101 in the absence and presence of GAP--334 at a molar ratio of 1:200 GAP:Ras. Results are the mean ± s.d. (n=4).](nihms411279f7){#F7}

[^1]: Present address: Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati Neuroscience Institute: Brain Tumor Center, University of Cincinnati, Ohio, USA.
